Table 4 Nuclear expression of β-catenin and non-phospho β-catenin on cut off value of 10% setting. Relationship with clinical outcome of COX-2 inhibitor therapy
Favorable group (n = 20) | Unfavorable group (n = 20) | p value | |
|---|---|---|---|
β-catenin | 0.38 | ||
≤ 10% | 2 | 4 | |
> 10% | 18 | 16 | |
non-phospho β-catenin | 0.022 | ||
≤ 10% | 16 | 9 | |
> 10% | 4 | 11 |